Literature DB >> 20338195

Microglial action in glioma: a boon turns bane.

Anirban Ghosh1, Swapna Chaudhuri.   

Abstract

Microglia has the potential to shape the neuroimmune defense with vast array of functional attributes. The cells prime infiltrated lymphocytes to retain their effector functions, play crucial role in controlling microenvironmental milieu and significantly participate in glioma. Reports demonstrate microglial accumulation in glioma and predict their assistance in glioma growth and spreading. Clarification of the 'double-edged' appearance of microglia is necessary to unfold its role in glioma biology. In this article the interpretation of microglial activities has been attempted to reveal their actual function in glioma. Contrary to the trendy acceptance of its glioma promoting infamy, accumulated evidences make an effort to view the state of affairs in favor of the cell. Critical scrutiny indicates that microglial immune assaults are intended to demolish the neoplastic cells in brain. But the weaponry of microglia has been tactically utilized by glioma in their favor as the survival strategy. Hence the defender appears as enemy in advanced glioma. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20338195     DOI: 10.1016/j.imlet.2010.03.003

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  17 in total

Review 1.  Microglial cell origin and phenotypes in health and disease.

Authors:  Kaoru Saijo; Christopher K Glass
Journal:  Nat Rev Immunol       Date:  2011-10-25       Impact factor: 53.106

2.  A much convenient and economical method to harvest a great number of microglia.

Authors:  Kun Qin; Ye-Hai Li; Ge Tian; Wei-Wei Xu; Peng Li; Run Zhang; Zheng-Yang Li; Xiao-Dan Jiang
Journal:  Cell Mol Neurobiol       Date:  2011-07-16       Impact factor: 5.046

Review 3.  CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought.

Authors:  Mary E Klein; Marta Kovatcheva; Lara E Davis; William D Tap; Andrew Koff
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

4.  Cyclin D1 and cdk4 mediate development of neurologically destructive oligodendroglioma.

Authors:  Daniel Ciznadija; Yuhui Liu; Stephanie M Pyonteck; Eric C Holland; Andrew Koff
Journal:  Cancer Res       Date:  2011-08-15       Impact factor: 12.701

5.  MerTK as a therapeutic target in glioblastoma.

Authors:  Jing Wu; Lauren N Frady; Ryan E Bash; Stephanie M Cohen; Allison N Schorzman; Yu-Ting Su; David M Irvin; William C Zamboni; Xiaodong Wang; Stephen V Frye; Matthew G Ewend; Erik P Sulman; Mark R Gilbert; H Shelton Earp; C Ryan Miller
Journal:  Neuro Oncol       Date:  2018-01-10       Impact factor: 12.300

6.  Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner.

Authors:  Jelena Põlajeva; Tobias Bergström; Per-Henrik Edqvist; Anders Lundequist; Anna Sjösten; Gunnar Nilsson; Anja Smits; Michael Bergqvist; Fredrik Pontén; Bengt Westermark; Gunnar Pejler; Karin Forsberg Nilsson; Elena Tchougounova
Journal:  Mol Oncol       Date:  2013-09-18       Impact factor: 6.603

Review 7.  The molecular profile of microglia under the influence of glioma.

Authors:  Wei Li; Manuel B Graeber
Journal:  Neuro Oncol       Date:  2012-05-09       Impact factor: 12.300

Review 8.  The roles of microglia/macrophages in tumor progression of brain cancer and metastatic disease.

Authors:  Shih-Ying Wu; Kounosuke Watabe
Journal:  Front Biosci (Landmark Ed)       Date:  2017-06-01

9.  Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12.

Authors:  Jelena Põlajeva; Anna M Sjösten; Nina Lager; Marianne Kastemar; Ida Waern; Irina Alafuzoff; Anja Smits; Bengt Westermark; Gunnar Pejler; Lene Uhrbom; Elena Tchougounova
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

10.  Antiangiogenic therapy for glioma.

Authors:  Valentina Cea; Carlo Sala; Chiara Verpelli
Journal:  J Signal Transduct       Date:  2012-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.